S100A12 and COVID-19: Moreover, in TNF-α activated monocytes, ITF3756 reduces the expression of additional biomarkers of severe COVID-19, such as PTX3, ICAM-1, S100A12, PD-L1 and MMP9, further supporting a potential role for this molecule in the treatment of the disease.